What are the risk factors for cerebral bleeding after thrombolysis (tissue plasminogen activator, tPA) for stroke?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risk Factors for Cerebral Bleeding After Thrombolysis for Stroke

The strongest predictor of intracranial hemorrhage after thrombolysis is the NIHSS score, with patients having NIHSS >20 carrying a 17% risk of symptomatic intracranial hemorrhage compared to only 3% in those with NIHSS <10. 1

Primary Risk Factors

Stroke Severity (Most Important)

  • NIHSS score is the single most powerful predictor of hemorrhagic transformation 1, 2
  • Patients with NIHSS >20 have nearly 6-fold higher risk compared to NIHSS <10 1
  • Stroke severity was identified as an independent risk factor in multiple systematic analyses 3

Age

  • Age ≥80 years is an independent risk factor for hemorrhagic transformation 2
  • Advanced age (>65 years) increases ICH likelihood 4
  • However, very old patients (≥80 years) do not have increased rates of symptomatic ICH compared to younger patients (2.6% vs 2.6%), though overall mortality is higher 5

Blood Pressure

  • Mean systolic pressure ≥140 mm Hg in the 24 hours after thrombolysis significantly increases hemorrhagic transformation risk 2
  • High systolic blood pressure at presentation is an independent risk factor 3
  • Blood pressure elevation is consistently associated with increased bleeding risk 1

Glucose and Diabetes

  • Elevated serum glucose >200 mg/dL is an independent risk factor 1
  • History of diabetes or elevated glucose was identified as a risk factor in six of twelve studies in systematic review 3

Secondary Risk Factors

Imaging Findings

  • Extent of hypoattenuation on pretreatment CT (indicating extensive ischemia) is a major independent risk factor 3
  • Major early CT changes indicating extensive ischemia increase bleeding risk 1

Coagulation Parameters

  • Low fibrinogen concentration before thrombolysis increases hemorrhagic transformation risk 2, 6
  • Prolonged activated partial thromboplastin time is associated with increased HT 6
  • Low platelet counts (<100,000) increase bleeding risk 6, 3
  • Low plasminogen activator inhibitor levels were identified as a risk factor 3

Cardiac Factors

  • History of atrial fibrillation increases hemorrhagic transformation risk 2
  • History of congestive heart failure is an independent risk factor 3

Protocol Deviations

  • Deviation from national treatment protocols significantly increases intracranial hemorrhage risk 1
  • Increased time to treatment is associated with higher bleeding risk 3

Additional Considerations

Structural Vascular Abnormalities

  • Unruptured intracranial aneurysms or arteriovenous malformations may increase hemorrhage risk, though limited data exists 7
  • Five cases with intracranial aneurysm detected after intraarterial thrombolysis resulted in 2 fatal intracranial hemorrhages 7

Other Factors

  • Smoking is associated with increased hemorrhagic transformation 6
  • Positive urinary protein expression correlates with increased bleeding risk 2
  • Low body weight (<70 kg) increases ICH likelihood 4

Clinical Context

The overall rate of symptomatic intracranial hemorrhage ranges from 3-9% in acute ischemic stroke patients treated with tPA 4, with recent large studies showing rates of approximately 6.4-7.3% 1, 7. When symptomatic ICH occurs, mortality rates exceed 60% 1, 4. Patients with multiple risk factors have substantially elevated risk, with likelihood ratios ranging from 0.34 (no risk factors) to 2.89 (three risk factors) 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.